Journal Of Clinical Oncology (jco) Podcast
Pembrolizumab is Safe and Active in Platinum- and Cetuximab-Refractory Head and Neck Squamous Cell Carcinoma
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:42
- Mas informaciones
Informações:
Sinopsis
By Amanda Psyrri The findings of KEYNOTE-055 are summarized and compared to other immunotherapy studies in recurrent/metastatic head and neck squamous cell carcinoma. Related Article: Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
